JP2014507470A - 組織から元素を除去するチオール含有化合物およびその製剤 - Google Patents

組織から元素を除去するチオール含有化合物およびその製剤 Download PDF

Info

Publication number
JP2014507470A
JP2014507470A JP2013557712A JP2013557712A JP2014507470A JP 2014507470 A JP2014507470 A JP 2014507470A JP 2013557712 A JP2013557712 A JP 2013557712A JP 2013557712 A JP2013557712 A JP 2013557712A JP 2014507470 A JP2014507470 A JP 2014507470A
Authority
JP
Japan
Prior art keywords
group
administration
hydrogen
alkyl
independently
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2013557712A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014507470A5 (https=
Inventor
ヘイリー，ボイド，イー．
アトウッド，デイヴィッド，エイ．
グプタ，ニラドリ，エヌ．
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Kentucky Research Foundation
Original Assignee
University of Kentucky Research Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Kentucky Research Foundation filed Critical University of Kentucky Research Foundation
Publication of JP2014507470A publication Critical patent/JP2014507470A/ja
Publication of JP2014507470A5 publication Critical patent/JP2014507470A5/ja
Withdrawn legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/695—Silicon compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/795—Polymers containing sulfur
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/04—Chelating agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D53/00—Separation of gases or vapours; Recovering vapours of volatile solvents from gases; Chemical or biological purification of waste gases, e.g. engine exhaust gases, smoke, fumes, flue gases, aerosols
    • B01D53/34—Chemical or biological purification of waste gases
    • B01D53/46—Removing components of defined structure
    • B01D53/64—Heavy metals or compounds thereof, e.g. mercury
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804—Compounds having Si-O-C linkages
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D2253/00—Adsorbents used in seperation treatment of gases and vapours
    • B01D2253/10—Inorganic adsorbents
    • B01D2253/106—Silica or silicates
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D2253/00—Adsorbents used in seperation treatment of gases and vapours
    • B01D2253/25—Coated, impregnated or composite adsorbents
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D2257/00—Components to be removed
    • B01D2257/60—Heavy metals or heavy metal compounds
    • B01D2257/602—Mercury or mercury compounds
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D2258/00—Sources of waste gases
    • B01D2258/02—Other waste gases
    • B01D2258/0283—Flue gases
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D2258/00—Sources of waste gases
    • B01D2258/02—Other waste gases
    • B01D2258/0283—Flue gases
    • B01D2258/0291—Flue gases from waste incineration plants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Emergency Medicine (AREA)
  • Toxicology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Analytical Chemistry (AREA)
  • Environmental & Geological Engineering (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pyridine Compounds (AREA)
JP2013557712A 2011-03-07 2012-01-06 組織から元素を除去するチオール含有化合物およびその製剤 Withdrawn JP2014507470A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US13/041,798 2011-03-07
US13/041,798 US8575218B2 (en) 2009-09-28 2011-03-07 Thiol-containing compounds for the removal of elements from tissues and formulations therefor
PCT/US2012/020418 WO2012121798A2 (en) 2011-03-07 2012-01-06 Thiol-containing compounds for the removal of elements from tissues and formulations therefor

Publications (2)

Publication Number Publication Date
JP2014507470A true JP2014507470A (ja) 2014-03-27
JP2014507470A5 JP2014507470A5 (https=) 2014-06-26

Family

ID=46798686

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013557712A Withdrawn JP2014507470A (ja) 2011-03-07 2012-01-06 組織から元素を除去するチオール含有化合物およびその製剤

Country Status (7)

Country Link
US (1) US8575218B2 (https=)
EP (1) EP2683370A4 (https=)
JP (1) JP2014507470A (https=)
CN (1) CN103442706A (https=)
AU (1) AU2012226279A1 (https=)
RU (1) RU2013141994A (https=)
WO (1) WO2012121798A2 (https=)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2017511307A (ja) * 2014-04-04 2017-04-20 エメレイムド リミテッド Ｎ，ｎ−ビス−２−メルカプトエチルイソフタルアミドの新規な使用

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8950583B2 (en) * 2008-12-06 2015-02-10 Ermes Medical Company Limited Method to remove heavy metals from a mammal
JP2013505963A (ja) * 2009-09-28 2013-02-21 ユニヴァーシティ オブ ケンタッキー リサーチ ファウンデイション 汚染された環境から元素を除去するチオール含有化合物およびその使用方法
US8426368B2 (en) * 2010-03-25 2013-04-23 The University Of Kentucky Research Foundation Method of ameliorating oxidative stress and supplementing the diet
GB2526623A (en) 2014-05-30 2015-12-02 Ermes Medical Company Ltd New pharmaceutical use
US9802889B2 (en) 2014-12-02 2017-10-31 Covalent Research Technologies, LLC Solid supported trithiol compounds for removing heavy metals from solution, and filtration systems utilizing the compounds
US20160367620A1 (en) 2015-06-19 2016-12-22 Harry B. Demopoulos Glutathione
WO2018025049A1 (en) 2016-08-05 2018-02-08 Emeramed Limited New use of n,n-bis-2-mercaptoethyl isophthalamide
MX2021005888A (es) * 2018-11-26 2021-06-23 Procter & Gamble Preparacion farmaceutica solida que contiene acido lipoico y uso de esta.
EP3976233A4 (en) * 2019-05-29 2023-07-26 Alliance for Sustainable Energy, LLC SEQUESTRATION COMPOSITIONS AND MATERIALS
GB202005057D0 (en) 2020-04-06 2020-05-20 Emeramed Ltd New Use
CN114642681B (zh) * 2022-03-18 2023-08-29 中国科学院长春应用化学研究所 一种聚合物在顺铂解毒中的应用
WO2026037909A1 (en) 2024-08-16 2026-02-19 Emeramed Limited N,n-bis-2-mercaptoethyl isophthalamide for use in the treatment of pain
GB202413573D0 (en) 2024-09-13 2024-10-30 Emeramed Ltd New pharmaceutical use

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4039446A (en) 1972-06-28 1977-08-02 Sumitomo Chemical Company, Limited Heavy metal-binding agent process
US4281086A (en) 1978-12-11 1981-07-28 The University Of Illinois Foundation Polymer bound multidentate complexes
JPS57102852A (en) 1980-12-19 1982-06-26 Shionogi & Co Ltd Dicarboxylic acid diamide
DE3174885D1 (en) 1981-02-03 1986-07-31 Ici Plc Process for the extraction of metal values and novel metal extractants
DE3231982A1 (de) 1982-08-27 1984-03-01 Süd-Chemie AG, 8000 München Thiolathaltiges mittel und verfahren zur entfernung von schwermetallionen aus verduennten waessrigen loesungen
US4673562A (en) 1983-08-19 1987-06-16 The Children's Medical Center Corporation Bisamide bisthiol compounds useful for making technetium radiodiagnostic renal agents
US4751286A (en) 1985-11-19 1988-06-14 The Johns Hopkins University Protein label and drug delivery system
US5200473A (en) 1988-03-25 1993-04-06 Jeanneret Gris Gilbert Chelating resins and method for their use in the extraction of metal ions
US4969995A (en) 1988-08-26 1990-11-13 The United States Of America As Represented By The United States Department Of Energy Removal of metal ions from aqueous solution
US5073575A (en) 1988-08-26 1991-12-17 The Regents Of The University Of California Cadmium ion-chelating synthetic polymers and process thereof
US5173470A (en) 1991-08-09 1992-12-22 Brigham Young University Compositions and processes for removing, separating and concentrating desired ions from solutions using sulfur and aralkyl nitrogen containing ligands bonded to inorganic supports
US5494935A (en) 1992-01-17 1996-02-27 University Of Utah Research Foundation Methods for oral decorporation of metals
SE508881C2 (sv) 1994-03-02 1998-11-16 Ctc Medical Ab Preparat avsett att vid behandling av i tänder befintliga amalgamfyllningar och/eller vid inserering av nya amalgamfyllningar hämma frisättning av Hg från amalgamet och/eller oskadliggöra frisatt Hg
US5615862A (en) 1995-02-02 1997-04-01 Gaudette; Robert M. Metal precipitation composition for treating spent dry film stripping solution
US5766478A (en) 1995-05-30 1998-06-16 The Regents Of The University Of California, Office Of Technology Transfer Water-soluble polymers for recovery of metal ions from aqueous streams
US6126964A (en) 1996-01-04 2000-10-03 Mirus Corporation Process of making a compound by forming a polymer from a template drug
US6896899B2 (en) 1996-12-31 2005-05-24 Antioxidant Pharmaceuticals Corp. Pharmaceutical preparations of glutathione and methods of administration thereof
AU741546B2 (en) 1997-07-24 2001-12-06 Perseptive Biosystems, Inc. Conjugates of transporter peptides and nucleic acid analogs, and their use
US6936729B2 (en) 1998-05-16 2005-08-30 Mirus Bio Corporation Compound containing a labile disulfide bond
US7087770B2 (en) 1998-05-16 2006-08-08 Mirus Bio Corporation Compound containing a labile disulfide bond
US6586600B2 (en) 2000-12-06 2003-07-01 University Of Kentucky Research Foundation Multidentate sulfur-containing ligands
EA200301204A1 (ru) 2001-04-30 2004-04-29 Тромсдорф ГмбХ унд Ко.КГ Арцнаймиттель Фармацевтически активные производные нуклеозида, способ их получения, их применение (варианты) и содержащая их фармацевтическая композиция, способ профилактики и/или лечения заболеваний и нарушений млекопитающих (варианты), комбинация лекарственных средств и ее применение (варианты)
US20040132101A1 (en) 2002-09-27 2004-07-08 Xencor Optimized Fc variants and methods for their generation
US20060099239A1 (en) 2002-04-15 2006-05-11 Coleman Henry D Dietary supplement for promoting removal of heavy metals from the body
US6852369B1 (en) 2002-09-05 2005-02-08 University Of Kentucky Research Foundation Method for prevention of solid dissolution through covalent ligand bonding
US20060115555A1 (en) 2004-12-01 2006-06-01 Foulger Sidney W Nutritional supplements containing xanthone extracts
EP1901701A4 (en) 2005-05-24 2012-05-02 David M Ott BODY CARE AND MEDICAL PRODUCTS WITH JOINED SULFUR ORGANIC GROUPS
WO2007041283A2 (en) 2005-09-30 2007-04-12 Patrick James Baggot Maternal chelation for embryo, fetal, and infant benefit
US8950583B2 (en) 2008-12-06 2015-02-10 Ermes Medical Company Limited Method to remove heavy metals from a mammal
JP2013505963A (ja) * 2009-09-28 2013-02-21 ユニヴァーシティ オブ ケンタッキー リサーチ ファウンデイション 汚染された環境から元素を除去するチオール含有化合物およびその使用方法
US8426368B2 (en) 2010-03-25 2013-04-23 The University Of Kentucky Research Foundation Method of ameliorating oxidative stress and supplementing the diet

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2017511307A (ja) * 2014-04-04 2017-04-20 エメレイムド リミテッド Ｎ，ｎ−ビス−２−メルカプトエチルイソフタルアミドの新規な使用

Also Published As

Publication number Publication date
US8575218B2 (en) 2013-11-05
US20110160150A1 (en) 2011-06-30
AU2012226279A1 (en) 2013-09-19
EP2683370A4 (en) 2014-10-15
RU2013141994A (ru) 2015-04-20
WO2012121798A2 (en) 2012-09-13
CN103442706A (zh) 2013-12-11
EP2683370A1 (en) 2014-01-15

Similar Documents

Publication Publication Date Title
JP2014507470A (ja) 組織から元素を除去するチオール含有化合物およびその製剤
US9907787B2 (en) Method of supplementing the diet and ameliorating oxidative stress
US8426368B2 (en) Method of ameliorating oxidative stress and supplementing the diet
US11110068B2 (en) Compositions comprising a dendrimer-resveratrol complex and methods for making and using the same
US9492551B2 (en) Orally administrable gallium compositions and methods of use
EP3295935B1 (en) Crystallization method and bioavailability
HUE025151T2 (en) Diceto-piperazine salts for drug delivery
CN102603866B (zh) 基于寡肽的pH敏感型两性离子及其在药剂中的应用
TWI461226B (zh) 包含至少一種經保護而免受消化酶影響之蛋白質活性成份的醫藥組合物
JP2010535198A (ja) コハク酸のコリン塩を含む鼻腔内投与用医薬品組成物
PH12014501981B1 (en) Method for producing enteric alginate microcapsules via ionic gelation containing diclofenac or one of the salts thereof and multiparticled pharmaceutical composition containing them
CA2828395A1 (en) Thiol-containing compounds for the removal of elements from tissues and formulations therefor
WO1991017751A1 (en) Orally administrable gallium compositions and methods of treatment therewith
ES2692165B2 (es) Sistema de liberacion controlada y metodo de preparacion del mismo
CN119371651B (zh) 一种靶向Bcr-Abl的自组装纳米材料的制备方法及其用途
EP4294383A1 (fr) Composition pour renforcer le systeme immunitaire
CN104140422A (zh) 具有快速皮肤穿透速度的带正电荷的水溶性的昔康及其相关化合物的前药
EA047084B1 (ru) Состав производного пиридинона системного действия от глютеновой болезни
JPH0635394B2 (ja) 薬物の溶解性および吸収性の改善方法

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20140224

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20140224

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20140416

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20140421

A761 Written withdrawal of application

Free format text: JAPANESE INTERMEDIATE CODE: A761

Effective date: 20150122